01
Beyond visual assessment
Move from appearance alone toward objective, quantitative measurements of cellular metabolic activity.
Australian biotechnology venture
See more than morphology.
VitaLens Bio is developing non-invasive metabolic imaging technologies for reproductive cell health — combining optical imaging, micro-optics and AI-powered analysis to turn complex images into objective, quantitative information.
The challenge
Reproductive cells contain information we cannot see by morphology alone.
Current reproductive-cell assessment relies heavily on visual examination, while other approaches may require additional intervention. VitaLens Bio is exploring a complementary approach: using naturally occurring optical signals to investigate cellular metabolism without introducing external labels.
02
Measure without labels
Use intrinsic optical signals to investigate living reproductive cells without adding fluorescent labels.
03
Turn images into information
Develop AI and image-analysis methods that extract reproducible metabolic features from complex imaging data.
Our technology
From metabolic images to quantitative insight.
VitaLens Bio is developing an integrated platform in which optical hardware, image acquisition and AI-based analysis are designed together — creating a pathway from cellular optical signals to measurable metabolic information.
Optical imaging
Capture naturally occurring optical signals associated with cellular metabolism using non-invasive imaging methods.
Micro-optics & instrumentation
Develop compact optical systems, acquisition workflows and instrumentation designed for repeatable, sensitive measurements.
AI & quantitative image analysis
Build analytical methods that process VitaLens Bio imaging data, quantify metabolic activity and identify reproducible patterns that can be validated against relevant biological outcomes.
How it works
A complete measurement pathway.
The goal is not simply to generate an image. It is to create a reproducible workflow that links image acquisition, computational analysis and biological interpretation.
01
Image
Acquire non-invasive optical images from reproductive cells.
02
Process
Standardise, quality-control and prepare imaging data for analysis.
03
Analyse
Use quantitative image analysis and AI to extract metabolic features.
04
Validate
Test reproducibility and biological relevance across appropriate models.
Development pathway
Building from research toward a practical technology.
VitaLens Bio is progressing through a staged development pathway focused on prototype performance, analytical capability and biological validation before later translation activities.
Phase 01
Alpha prototype
Develop the integrated imaging platform and validate hardware accuracy, image acquisition and software performance.
Phase 02
AI & metabolic analysis
Develop reproducible analytical methods that quantify metabolic activity from images generated by the platform.
Phase 03
Biological validation
Investigate the relationship between imaging-derived metabolic measurements and relevant biological outcomes.
Phase 04
Technology translation
Build the engineering, regulatory and commercial foundations required for future real-world application.
Research & collaboration
Multidisciplinary by design.
Developing metabolic imaging technology requires expertise across optics, engineering, reproductive biology, AI and data science. VitaLens Bio is building collaborations that bring these disciplines together around shared technology-development and validation challenges.
Our team
Engineering and reproductive science, together.
VitaLens Bio combines complementary expertise in reproductive medicine, reproductive science, micro-optics, imaging systems and technology development.
Dr Fabrizzio Horta Nunez
Founder · Co-CEO / Chief Scientific Officer
Reproductive medicine and reproductive science, with a focus on the biological development and translation of VitaLens Bio's technology.
Dr Erick Vargas-Ordaz
Co-founder · Chief Technology Officer
Micro-optics, microsystems, biomedical imaging and engineering, leading the development of imaging systems, instrumentation, automation and quantitative analysis.
Partner with us
Help us build the next generation of metabolic imaging.
VitaLens Bio is interested in research, technology, biological-validation and investment partnerships that can help advance non-invasive metabolic imaging for reproductive cell health.
Add your preferred VitaLens Bio contact email or enquiry form before publishing this page.